CORTEF (hydrocortisone) by Pfizer is corticosteroid hormone receptor agonists [moa]. First approved in 1952.
Drug data last refreshed 2h ago · AI intelligence enriched 6d ago
CORTEF (hydrocortisone) is an oral corticosteroid tablet that acts as a hormone receptor agonist to suppress inflammation and immune responses. It is indicated for adrenal insufficiency, inflammatory conditions, and allergic disorders. The drug works by binding to glucocorticoid receptors to reduce cytokine production and inflammatory cell activation.
Product approaching loss of exclusivity with moderate competitive pressure (30% intensity) signals defensive positioning and potential team restructuring or transition planning.
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction
Worked on CORTEF at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moZero linked job postings reflect CORTEF's mature, stable market position with minimal expansion hiring. Career opportunities are concentrated in defensive commercial and operational roles rather than growth-focused functions.